Quotes 5-day view Delayed Nasdaq
05/20/2013
05/21/2013
05/22/2013
05/23/2013
05/24/2013
Date
100.03(c)
102.67(c)
100.57(c)
99.88(c)
99.17(c)
Last
914 398
1 020 276
1 131 564
779 971
679 584
Volume
-2.79% +2.64% -2.05% -0.69% -0.71% Change
Alexion Pharmaceuticals specializes in the research and development of therapeutic products used in treating hematological and cardiovascular diseases, auto-immune diseases, and cancers.
At the end of 2012, the group had a portfolio of 15 products in clinical development of which 11 in Phase II, 2...
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
Chart ALEXION PHARMACEUTICALS, I
Duration :
Auto.
2 month
3 month
6 month
9 month
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Sales 2013
1 517 M
EBIT 2013
644 M
Net income 2013
426 M
Finance 2013
1 251 M
Yield 2013
-
Sales 2014
1 889 M
EBIT 2014
866 M
Net income 2014
574 M
Finance 2014
1 804 M
Yield 2014
-
PER 2013
47,74
PER 2014
34,71
EV / Sales 2013
11,9x
EV / Sales 2014
9,29x
Capitalization
19 353 M
Latest news on ALEXION PHARMACEUTICALS, I
2d ago ALEXION PHARMACEUTICALS, INC. : Alexion to Present at the Deutsche Bank 38th Ann..05/08 ALEXION PHARMACEUTICALS, INC. : Alexion to Present at the BofA Merrill Lynch 201..04/25 ALEXION PHARMACEUTICALS, INC. : Alexion Reports First Quarter 2013 Results04/25 ALEXION PHARMACEUTICALS, INC. : Alexion Broadens and Strengthens its Executive L..04/11 ALEXION PHARMACEUTICALS, INC. : Alexion Pharmaceuticals to Report First Quarter ..03/14 ALEXION PHARMACEUTICALS, INC. : Alexion Joins the International Federation of Ki..03/05 ALEXION PHARMACEUTICALS, INC. : Alexion to Present at the Barclays Global Health..02/28 ALEXION PHARMACEUTICALS, INC. : Alexion Joins Eurordis, NORD and Patient Organiz..02/25 ALEXION PHARMACEUTICALS, INC. : Alexion to Present at the Cowen and Company 33rd..02/19 ALEXION PHARMACEUTICALS, INC. : StockCall Scrutinizes Alexion Pharma and Celgene..02/14 ALEXION PHARMACEUTICALS, INC. : Alexion Reports Fourth Quarter and Full Year 201..02/11 ALEXION PHARMACEUTICALS, INC. : quaterly earnings release
Forum ALEXION PHARMACEUTICALS, I
Technical analysis trends
Short Term Mid-Term Long Term Trends Neutral Bullish Neutral
